Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

14.00 +0.09 (+0.65%)
Delayed Quote Updated: 1:02 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares
From AbCellera Biologics Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
News headline image
New New Deal Worries ↗
Nio is up 1.4% today on another round of Meme buying. 
Via Talk Markets
News headline image
The Surprising Move Vir Stock Made After Winning Covid Drug Authorization ↗
GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday. 
Via Investor's Business Daily
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... 
Via Benzinga
News headline image
Sterling At Five-Year High ↗
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
News headline image
Worldwide Upbeat ↗
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
News headline image
Another Tough Day For Markets ↗
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” 
Via Talk Markets
News headline image
CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Friday Of The Heavy Week ↗
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
News headline image
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug ↗
AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter. 
Via Investor's Business Daily
News headline image
AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript ↗
ABCL earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
AbCellera Reports Q1 2021 Business Results
From AbCellera Biologics Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
AbCellera to Present Virtually at Berenberg Conference on May 18, 2021
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Finns and Danes ↗
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
News headline image
Merry Month of May ↗
Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened. 
Via Talk Markets
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
News headline image
AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials ↗
AbCellera Biologics Inc (NASDAQ: ABCL) has announced that a second antibody from its collaboration with Eli Lilly and Co (NYSE: LLY), LY-CoV1404, ... 
Via Benzinga
News headline image
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
From AbCellera Biologics Inc.
Via Business Wire
News headline image
22 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... 
Via Benzinga
News headline image
AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals
From AbCellera
Via Business Wire
News headline image
Tuesday Market Report ↗
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April. 
Via Talk Markets
News headline image
London Cancel ↗
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon. 
Via Talk Markets
News headline image
Earth Day ↗
Once again the exchanges are unsure if they want to go up or down. 
Via Talk Markets
News headline image
AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
From AbCellera
Via Business Wire
News headline image
AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration
From AbCellera Biologics Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.